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graftingOn 4 May 1985 (in the former Soviet Union), endovascular
stent-graft surgery was performed for the ﬁrst time in the
world, thereby realizing the aspiration of Charles Dotter
that physicians should repair vessels remotely.1 At the time,
we termed the technique “remote endoprosthetic repair”.
The ﬁrst patient (aged 66 years) presented with lower
limb gangrene secondary to a stenosis of the iliac artery and
occlusions of the superﬁcial femoral and popliteal arteries,
with only one tibial vessel extending into the foot. The
patient underwent insertion of a self-ﬁxating synthetic
endoprosthesis within the stenosed iliac segment (Fig. 1)
followed by a femoro-tibial bypass using ipsilateral long
saphenous vein. The proximal end of the vein bypass and
the origin of the profunda femoris artery were joined to
create a common outﬂow trunk, which was anastomosed to
the distal aspect of the iliac endoprosthesis. Nowadays, this
procedure would be called a “hybrid operation”. The iliac
endoprosthesis and vein bypass functioned well for a year,
until the patient died following an acute stroke.2 In total, we
performed 18 stent-graft procedures in the iliac arteries.We
deliberately experimented with “remote endoprosthetic
repair” within the iliac segment because the risks of inter-
vening were lower and it would be relatively easy to treat
any complications that arose using conventional open
surgery.
Of course, others were interested in developing endo-
vascular techniques and Juan Parodi performed his seminal
procedure in September 1990, some 5 years after our ﬁrst
experience. Accordingly, some readers may be interested in
understanding how our research programme evolved at a
time when we were unable to “borrow” from other sur-
geons’ experiences and in the absence of critical evaluation
or comments from others. From the very beginning,
endoprosthetic repair of the iliac arteries was not our pri-
mary goal, and we were already beginning to experiment
with the insertion of stent-grafts into the thoracic and
abdominal aortas using models and cadavers, while we
waited for suitable clinical cases to present.
In March 1987, a patient was referred with a post-
traumatic false aneurysm of the descending thoracic
aorta, which was successfully treated by insertion of a stent-
graft delivered via the femoral artery. This patient subse-
quently lived for > 18 years with a well-functioning1078-5884/$ e see front matter  2015 European Society for Vascular
Surgery. Published by Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.ejvs.2015.02.012endoprosthesis, with no evidence of endoleaks or graft
malfunction, before succumbing to an acute myocardial
infarction.3 In 1989, we attempted to insert a stent-graft
into an abdominal aortic aneurysm (using a one-piece
bifurcated prosthesis using bilateral femoral access) but,
unfortunately, the unstented contralateral limb became
twisted and the procedure had to be completed via
“traditional” open surgery.
In June 1991, our endovascular experience extended into
complex pathologies of the aortic arch. On this occasion, we
undertook a hybrid procedure to treat an arch aneurysm
involving the origins of the left subclavian and left carotid
arteries, which had developed following treatment of a
coarctation 17 years previously. The origin of the left carotid
artery was transposed on to the brachiocephalic trunk and a
left carotid subclavian bypass performed (an early example
of what would subsequently become known as
“debranching”). After performing a median sternotomy, a
14-mm polyester graft was then anastomosed to the
ascending aorta and this (in conjunction with femoral ac-
cess) facilitated “through and through” access for guide
wires, catheters, and graft deployment systems. The endo-
prosthesis was then inserted retrogradely via the arch ac-
cess graft, with traction provided via the femoral access
point. This stent-graft has now been functioning without
signiﬁcant complication for > 23 years.4
In 1993, we successfully treated a patient with massive
lung hemorrhage secondary to an aorto-bronchial ﬁstula via
insertion of a stent graft using axillary and femoral access.
This patient had developed a false aneurysm of the
descending thoracic aorta following patch angioplasty of a
thoracic coarctation 26 years earlier. This patient subse-
quently lived for 18 years with a normally functioning
endoprosthesis.5 On 12 May 1993, we successfully under-
took stent-grafting of an abdominal aortic aneurysm using a
one-piece bifurcated endoprosthesis delivered via bilateral
femoral access.6,7 In 1997, a novel hybrid endovascular
approach was developed for treating patients with various
combinations of abdominal aortic aneurysm, stenoses, or
occlusion of the aorto-iliac vessels using the left common
iliac artery as the access vessel, which was exposed via a
lower left paramedian incision.8
Overall, our group performed 94 stent-grafting pro-
cedures during the development phase of our clinical
research project involving pathologies of the thoracic aorta,
abdominal aorta, and iliac arteries. However, a lot of
experimental work preceded the introduction of
Figure 1. Professor Nikolay Volodos (right) and his team preparing the ﬁrst stent-graft delivery system for the ﬁrst experimental procedure
in 1984.
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1983, we focused on developing strategies for enabling less
traumatic repairs of the aorta. The key to success was
designing a self-ﬁxating synthetic endoprosthesis. Our ef-
forts to create a structure that could make the prosthesis
capable of ‘self-ﬁxating’, while at the same time being able
to change its diameter depending on native vessel diameter,
led us to invent a patented radial “zigzag spring” as the
ﬁxating element of the endoprosthesis.9,10 Interestingly, a
similar structure (the Gianturco stent) was patented 5
months later.11 Having researched the various radial forces
that were needed to ﬁx the endoprosthesis in cadaveric
aortas under pulsatile ﬂow conditions, we subsequently
carried out experiments in large animal models, which
demonstrated good functioning and compatibility of the
endoprosthesis. This then allowed us to move to the clinical
stage of our research programme.
Looking back, some colleagues have criticized our group
for not being particularly active in publishing our work in
English-language journals and that we (perhaps) did not
share our experiences with others. However, while it is true
that our initial data were published in domestic journals
(starting in 1985), our group was active in disseminating our
research and clinical experiences throughout the world. This
included international presentations at the International
Congress on Interventional Radiology and Cardiovascular
Pathology in Toulouse (1990), the tripartite German, Aus-
trian and Swiss Vascular Society in 1991, as well as the
European Society of Vascular Surgery in 1992. These pre-
sentations were subsequently followed up with invited
lectures at the Phoenix and Veith meetings.
The evolution of endovascular stent-graft repair over the
last three decades has served as a catalyst for otherimportant developments in minimally invasive vascular
practices, and these are to be welcomed.12 First, the new
technique required accurate anatomic data, which was an
impetus to re-evaluate all aspects of aortic anatomy and
pathology, which (inevitably) required a focus on developing
better-quality imaging strategies. Second, the emergence of
endovascular repair opened up new and less invasive op-
tions for treating dissection and other complex aortic pa-
thologies. Third, the new technology served as a catalyst for
other innovators to develop newer kinds of endopros-
theses, including branched and fenestrated devices, as well
as the introduction of chimneys, snorkels, and sandwich
grafts, as well as the evolution of transcatheter aortic valve
implantation devices. These newer technologies now enable
experienced practitioners to treat ever more complex arch
and thoraco-abdominal pathologies, thereby increasing the
options available to many patients who might previously
have been considered inoperable.
In conclusion, I was fortunate to have been present at the
very beginning of the era of “endovascular repair”, which
others (quite rightly) have called the “endovascular revo-
lution”. In addition to paying tribute to my surgical and
research team, it is also important for me to acknowledge
those colleagues who have actively promoted recognition of
the research undertaken by our unit during this pioneering
period. These include Krassi Ivancev, Frank Veith, Edward
Dietrich, Martin Bjorck, Alexei Svetlikov, and Leo Bokeria.ADDENDUM
As a tribute to the pioneering career of Professor Volodos,
the European Society of Vascular Surgery will be awarding
him an honorary Fellowship of the Society.
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